Form Type: 4

SEC EDGAR Link
Accession Number:0001415889-21-002920
Date:2021-06-08
Issuer: IDERA PHARMACEUTICALS, INC. (IDRA)
Original Submission Date:

Reporting Person:

DOUGHERTY MICHAEL R
C/O IDERA PHARMACEUTICALS, INC.
505 EAGLEVIEW BOULEVARD, SUITE 212 EXTON, PA 19341

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 1.31 2021-06-08 deemed execution date A 26,000 (a) 2022-06-08 2031-06-08 common stock 26,000 $1.31 26,000 direct
Footnotes
IDfootnote
f1 non-qualified stock options granted, under the issuer's 2013 stock incentive plan, on the date of the issuer's 2021 annual meeting of stockholders at an exercise price equal to the closing price of the issuer's common stock on the date of grant, pursuant to the issuer's director compensation policy.
f2 the options vest in full and become immediately exercisable on june 8, 2022 (first anniversary of the date of grant), subject to continued service as a director of the issuer.

Elevate your investments